Related Experiment Video
Updated: Sep 2, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Bronchopulmonary Dysplasia: Development and Progression in the Neonatal Intensive Care Unit
1Division of Neonatology, Department of Pediatrics, The Johns Hopkins University, Baltimore, Maryland.
Advances in neonatology improve survival for premature infants, but bronchopulmonary dysplasia (BPD) remains a challenge. Strategies focus on minimizing inflammation and injury, with further research needed for new therapies.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Critical Care Medicine
Background:
- Neonatal care advances increase survival rates for extremely preterm infants.
- Bronchopulmonary dysplasia (BPD) is a common complication despite technological improvements.
- BPD results from abnormal pulmonary development influenced by oxygen, ventilation, and inflammation.
Purpose of the Study:
- To review the challenges and current understanding of bronchopulmonary dysplasia (BPD) in extremely preterm infants.
- To discuss strategies for preventing and treating BPD, focusing on inflammation.
- To evaluate the potential of novel anti-inflammatory therapies.
Main Methods:
- Review of current literature on neonatal respiratory support and BPD.
- Analysis of factors contributing to abnormal pulmonary development in preterm infants.
- Discussion of emerging therapeutic strategies targeting inflammation.
Main Results:
- Increased survival of premature infants is associated with a higher incidence of BPD.
- Minimizing hyperoxia, ventilator injury, and infection are key preventive measures.
- The role of steroids and inhaled nitric oxide in BPD management requires further investigation.
Conclusions:
- Bronchopulmonary dysplasia (BPD) is a complex multifactorial disease in extremely preterm infants.
- Preventive strategies should focus on reducing lung injury and inflammation.
- Further research is essential to establish the safety and efficacy of new anti-inflammatory treatments for BPD.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
04:21A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
Published on: August 4, 2021
Related Concept Videos
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-I: Introduction
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: